Actively Recruiting
This is a Study to Evaluate Nanofractures Technique in the Treatment of Cartilage Lesions
Led by Ente Ospedaliero Cantonale, Bellinzona · Updated on 2025-08-06
20
Participants Needed
1
Research Sites
200 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Articular cartilage lesions, with their inherent limited healing potential, remain a challenging problem for orthopaedic surgeons. Various techniques, both palliative and reparative, have been used to treat this injury with variable success rates. If not adequately treated, they may even lead to the development of early-onset osteoarthritis. Among all the available techniques, microfractures are used in restoring the cartilage tissue, especially in the deep and extended lesions. More recently, the need for minor bone trauma with still adequate bleeding resulted in the development of nanofractures. Nanofracturing means creating perforations with a smaller diameter that go deeper into the bone while damaging it less. This is supposed to reduce the injury to the subchondral bone and increase the amount of bone marrow-derived mesenchymal stromal cells at the bone surface. Thus, the aim of this pilot study is to evaluate the efficacy of nanofractures for the treatment of cartilage lesions of the knee, specifically focusing on the chondral healing that will be addressed with magnetic resonance imaging.
CONDITIONS
Official Title
This is a Study to Evaluate Nanofractures Technique in the Treatment of Cartilage Lesions
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with cartilage lesions of the knee scheduled for surgery
- Age between 16 and 50 years
- Body mass index (BMI) between 18.5 and 30
- Ability to give informed consent
You will not qualify if you...
- Uncorrected knee instability
- Meniscectomy more than 50%
- Uncorrected knee misalignment
- Uncontrolled metabolic diseases
- Inability to give informed consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
EOC
Lugano, Switzerland, 6900
Actively Recruiting
Research Team
A
Alessandro Sangiorgio, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here